Skip to content

Biofourmis Everion+ (G2)

by Biofourmis Singapore Pte., Ltd.

510(k) K233418

Biofourmis Everion+ (G2) is a medical device (FDA Class II; FDA product code MSX, System, Network And Communication, Physiological Monitors) made by Biofourmis Singapore Pte., Ltd., cleared under FDA 510(k) K233418 on 9 May 2024, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK233418 Date9 May 2024ClearedStatusActive

Official records

From the FDA record

Received by the FDA
10 Oct 2023
FDA decision
9 May 2024 (Substantially Equivalent)
FDA review time
212 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K233418 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MSX
Device class
Class II
Regulation
21 CFR Part 870.2300
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code MSX (System, Network And Communication, Physiological Monitors).

Other devices from Biofourmis Singapore Pte., Ltd.

See all devices from Biofourmis Singapore Pte., Ltd. →